KH
Kim Hyo-Gi
Ceo - Chief Executive Officer at Celemics,
View Kim's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Ceo - Chief Executive Officer
Present
Company Details
51-200 Employees
Celemics is a Next Generation Sequencing (NGS) full solution provider based on target enrichment technology. We confidently offer custom target enrichment panels and high-quality pre-set panels, covering fields such as Inherited Diseases, Oncology, Immunology, and Pathogen Diagnostics. With 13 years of experience, we will provide the best solution for your Targeted Sequencing. [Products/Services] OncoRisk (Hereditary Cancer) | CancerScreen (Somatic Cancer) | Custom Target Enrichment Panel | Whole Exome Sequencing | Clinical Exome Sequencing | BRCA 1/2 | PharmacoScreen | Comprehensive Respiratory Virus | Agrigenomics
Year Founded
2010
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research, Laboratory equipment, biological, Chemical industry plant and equipment, Chemicals, Pharmaceuticals & Plastics, Laboratory equipment, specialised, Genetic and biological engineering research and development, Research and testing, IT, Internet, R&D, Genetic analysis services, Research, general
HQ Location
19-20F, BYC Highcity Bldg. A Gasandigital 1-ro 131 Seoul, Geumcheon-gu 08506, KR
Keywords
NGSTarget SequencingWhole Exome PanelSomatic Cancer PanelClinical Exome PanelCustomized NGS PanelTarget Enrichment PanelNGS panelBioinformaticsBioinformatics Analysis
Discover More About Cleveland Clinic
Contact Details
  • Email AddressK**@celemics.com
    Reveal Email
  • Phone Number(xxx)xxx-xxxx
    Reveal Phone

Find verified contacts of Kim Hyo-Gi in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.